Your browser doesn't support javascript.
loading
BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.
Zong, Dali; Adam, Salomé; Wang, Yifan; Sasanuma, Hiroyuki; Callén, Elsa; Murga, Matilde; Day, Amanda; Kruhlak, Michael J; Wong, Nancy; Munro, Meagan; Ray Chaudhuri, Arnab; Karim, Baktiar; Xia, Bing; Takeda, Shunichi; Johnson, Neil; Durocher, Daniel; Nussenzweig, André.
  • Zong D; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Adam S; The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
  • Wang Y; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Sasanuma H; Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Callén E; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Murga M; Genomic Instability Group, Spanish National Cancer Research Center, CNIO, Madrid, Spain.
  • Day A; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Kruhlak MJ; Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Wong N; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Munro M; The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
  • Ray Chaudhuri A; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA; Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Karim B; Pathology/Histotechnology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Xia B; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Takeda S; Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Johnson N; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Durocher D; The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Nussenzweig A; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA. Electronic address: andre_nussenzweig@nih.gov.
Mol Cell ; 73(6): 1267-1281.e7, 2019 03 21.
Article en En | MEDLINE | ID: mdl-30704900
ABSTRACT
BRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1+/-RNF168-/- cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromatina / Proteína BRCA1 / Ubiquitina-Proteína Ligasas / Ubiquitinación / Haploinsuficiencia / Fibroblastos / Neoplasias Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromatina / Proteína BRCA1 / Ubiquitina-Proteína Ligasas / Ubiquitinación / Haploinsuficiencia / Fibroblastos / Neoplasias Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article